CETUXIMAB SAROTALOCAN SODIUM
UNII MG94W1I5XW

Substance Identification & Data

This profile provides standardized clinical and technical data for Cetuximab Sarotalocan Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MG94W1I5XW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2166339-33-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

MG94W1I5XW

CAS Registry Number

2166339-33-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CETUXIMAB SAROTALOCAN SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C121850

National Cancer Institute reference terminology for clinical and research data.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cetuximab Sarotalocan Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

CETUXIMAB SAROTALOCAN SODIUM

CETUXIMAB SAROTALOCAN SODIUM [JAN]

CETUXIMAB SAROTALOCAN SODIUM [WHO-DD]

CETUXIMAB-IRDYE 700DX CONJUGATE

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL (V-ERB-B) ONCOGENE HOMOLOG, ERBB)), CHIMERIC MONOCLONAL ANTIBODY CONJUGATED TO IRDYE 700DX (IR700) NEAR-INFRARED PHOTOSENSITIZING DYEGAMMA1 HEAVY CHAIN CHIMERIC (1-449) (VH (MUS MUSCULUS IGHV2-2*03 (93.8%)-(IGHD)-IGHJ3*01 (100%)) (8.7.13) (1-119)-HOMO SAPIENS IGHG1*03 (100%), G1M3, NG1M1 (CH1 R120 (216) (120-217), HINGE (218-232), CH2 (233-342), CH3 E12 (358), M14 (360) (343-447), CHS (448-449)) (120-449)), (222-214')-DISULFIDE WITH KAPPA LIGHT CHAIN CHIMERIC (1'-214') (V-KAPPA (MUS MUSCULUS IGKV5-48*01 (95.8%)-IGKJ5*01 (100%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (228-228'':231-231'')-BISDISULFIDECONJUGATED ON AN AVERAGE OF 2 OR 3 LYSYL TO PHOTOSENSITIZING DYE IRDYE 700DX

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER, AMIDE WITH SODIUM (OC-6-13)-(6-(((3-((29H,31H-PHTHALOCYANIN-1-YL-.KAPPA.N29,.KAPPA.N30,.KAPPA.N31,.KAPPA.N32)OXY)PROPOXY)CARBONYL)AMINO)HEXANOATO(2-))BIS(N-(3-((HYDROXY-.KAPPA.O)DIMETHYLSILYL)PROPYL)-3-SULFO-N,N-BIS(3-SULFOPROPYL)-1-PROPANAMINIUMATO(4-))SILICATE(4-) (4:1)

SYS